BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28612583)

  • 1. Use of proporanolol compounding from tablet in infantile hemangiomas.
    Yazici N; Sarialioglu F; Erbay A
    Minerva Pediatr; 2017 Aug; 69(4):369-370. PubMed ID: 28612583
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of oral propranolol for infantile hemangiomas started after 5 months of age.
    Lopez T; Miraglia E; Schiavetti A; Varrasso G; Calvieri S; Giustini S
    G Ital Dermatol Venereol; 2020 Feb; 155(1):115-116. PubMed ID: 29747482
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol treatment for hemangioma of infancy.
    Bonini FK; Bellodi FS; Souza EM
    An Bras Dermatol; 2011; 86(4):763-6. PubMed ID: 21987146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of infantile hemangiomas.
    Püttgen KB
    Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of intralesional bleomycin and oral propanolol in management of hemangiomas.
    Thayal PK; Bhandari PS; Sarin YK
    Plast Reconstr Surg; 2012 Apr; 129(4):733e-735e. PubMed ID: 22456397
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
    Tan ST; Itinteang T; Leadbitter P
    Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
    Casiraghi A; Musazzi UM; Franceschini I; Berti I; Paragò V; Cardosi L; Minghetti P
    Minerva Pediatr; 2014 Oct; 66(5):355-62. PubMed ID: 25253183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of infantile hemangiomas with propranolol: clinical guidelines.
    Szychta P; Stewart K; Anderson W
    Plast Reconstr Surg; 2014 Apr; 133(4):852-862. PubMed ID: 24352207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giving propranolol tablets to infants with hemangiomas - solubility in water.
    Greenhill NB; Deacon GB; Phillips RJ
    J Paediatr Child Health; 2011 Jul; 47(7):484-5. PubMed ID: 21771149
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
    Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
    Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for infantile haemangioma: a review of current dosing regime in a regional paediatric hospital.
    McGee P; Miller S; Black C; Hoey S
    Ulster Med J; 2013 Jan; 82(1):16-20. PubMed ID: 23620625
    [No Abstract]   [Full Text] [Related]  

  • 18. [Propanolol used in treatment of infantile hemangioma].
    Guldbakke KK; Rørdam OM; Huldt-Nystrøm T; Hanssen HK; Høivik F
    Tidsskr Nor Laegeforen; 2010 Sep; 130(18):1822-4. PubMed ID: 20882080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giving propranolol tablets to infants with hemangiomas.
    Nunn A; Shah U; Ford J
    J Paediatr Child Health; 2011 Dec; 47(12):927. PubMed ID: 22171835
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.